Psoriatar (Coal Tar)

Manufacturer
Nivagen Pharmaceuticals, Inc.
Effective date
2016-05-05
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:46:05

Label at a glance#

ProductPsoriatar (Coal Tar)
Active ingredientCoal Tar
Label structure10 sections

Dosage and administration

Shake the can before use. Invert the can to dispense. Upright dispensing will cause loss of propellant. Apply to affected areas one to four times daily or as directed by a doctor.

Storage and handling

Contents under pressure. Do not puncture or incinerate. Store at 68°-77°F (20°-25°C). Do not expose to heat or at temperatures above 120°F (49°C).

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Coal Tar 2% (from Coal Tar Topical Solution USP, 10%)

Purpose

OTC - PURPOSE SECTION

Psoriasis

Use

INDICATIONS & USAGE SECTION

for the relief of symptons of psoriasis

Warnings

WARNINGS SECTION

For external use only

Flammable

SPL UNCLASSIFIED SECTION

Avoid fire, flame, or smoking during and immediately following application.

Do not use

OTC - DO NOT USE SECTION

  • for prolonged periods without consulting a doctor
  • this product in or around the rectum or in the genital area or groin except on the advice of a doctor

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have a condition that covers large areas of the body.

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are using the product with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs.

OTC - WHEN USING SECTION

When using this product

  • avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
  • use caution in exposing skin to sunlight after applying this product. It may increase your tendency to sunburn for up to 24 hours after application.
  • Product can stain clothing, contact lenses and hair. To minimize staining, allow product to dry before contact.

OTC - STOP USE SECTION

Stop use and ask doctor if condition worsens or does not improve after regular use of this product as directed.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a poison control center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Shake the can before use.
  • Invert the can to dispense. Upright dispensing will cause loss of propellant.
  • Apply to affected areas one to four times daily or as directed by a doctor.

Other Information

STORAGE AND HANDLING SECTION

  • Contents under pressure. Do not puncture or incinerate.
  • Store at 68°-77°F (20°-25°C).
  • Do not expose to heat or at temperatures above 120°F (49°C).

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Alcohol denatured, caprylic/capric triglyceride, ceteareth-20, cyclopentasiloxane, dimethicone, disodium edta, glycerin, hydroxypropyl methylcellulose, isobutane, isopropyl myristate, mentha piperita (peppermint) oil, phenoxyethanol, polysorbate 80, potassium sorbate, propane, sodium chloride, sodium citrate, stearic acid, water (aqua), xantham gum

Questions?

OTC - QUESTIONS SECTION

1-877-977-0687

PRINCIPAL DISPLAY PANEL - 100 g Can Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

75834-101-01
PSORIASIS FOAM

Psoriatar™

(Coal Tar) Foam 2%

NIVAGEN
PHARMACEUTICALS

Net wt. 3.5 oz (100 g)

PRINCIPAL DISPLAY PANEL - 100 g Can Label
PRINCIPAL DISPLAY PANEL - 100 g Can Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
824335crude coal tar 2 % Topical FoamPSN1
824335coal tar 20 MG/ML Topical FoamSCD1
824335coal tar 2 % Topical FoamSY1
824335crude coal tar 2 % (coal tar solution 10 % ) Topical FoamSY1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
75834-101-012020-01-31C16284748780-19d75b9d0-f1bd-f424-e053-dadaa90a57cePsoriatar ™ (Coal Tar) Foam, 2% coal tar foam

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
75834-101-01Psoriatar (Coal Tar)100 g in 1 CANAEROSOL, FOAM1001
75834-101-01Psoriatar (Coal Tar)1 in 1 CARTONAEROSOL, FOAM11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
75834-101PSORIATAR (COAL TAR) (COAL TAR) AEROSOL, FOAM [NIVAGEN PHARMACEUTICALS, INC.]1Legacy NDC, 2 package rows20160524_bce479c0-6695-4580-9a87-1df69007cea4.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 22 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
75834-10175834-101-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 21 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
a359840c-60f8-44e8-903e-bc01b2df2c83bce479c0-6695-4580-9a87-1df69007cea42026-09-01WarningsExact identifier
spl set id: bce479c0-6695-4580-9a87-1df69007cea4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.